TLR4 and cancer: Recently, it was reported that CXCL10 contributes to hepatocellular apoptosis through TLR4 on MDSCs instead of its common receptor—CXC motif receptor 3—in patients with hepatocellular carcinoma (HCC), thus leading to cancer recurrence.